Segmed Appoints David Gascoigne as CEO Amid Leadership Changes

Segmed has appointed David Gascoigne as its new CEO, transitioning co-founder Dr. Martin Willemink to Chief Scientific Officer and adding Dr. Yin Ho to its Board of Directors.

Segmed has appointed David Gascoigne as its new Chief Executive Officer, announced in a press release. This leadership transition also sees co-founder Dr. Martin Willemink moving to the role of Chief Scientific Officer, while Dr. Yin Ho joins the Board of Directors.

David Gascoigne brings over 30 years of experience in healthcare, life sciences, and AI, having previously served as CEO of Almaden Genomics. His appointment comes as Segmed aims to expand its reach and innovation in medical imaging and AI-driven healthcare solutions.

Dr. Martin Willemink, who has led Segmed through significant growth and funding rounds, will now focus on advancing the company's scientific vision and market presence. Meanwhile, Dr. Yin Ho, with her extensive background in healthcare IT and clinical research, will contribute strategic insights as an Independent Director.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish like Life AI Weekly.

Also, consider following us on social media:

Healthcare & Life Sciences AI

AI Brief (X)

More from: Healthcare & Life Sciences

Genesis Therapeutics Appoints Aleksandra Faust as Chief AI Officer

Jun 13

Ellipsis Health Unveils AI Care Manager Sage with $45M Funding

Jun 13

Deep Apple and Novo Nordisk Partner on Cardiometabolic Drug Discovery

Jun 13

Outcomes4Me Acquires Mika Health App to Enhance AI-Driven Cancer Care

Jun 13

AllSci Secures Grant to Enhance AI Platform for Pharma and Biotech

Jun 11

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.